• Bio4Dreams portfolio company OaCP secured ISO 13485:2016 certification for its quality system covering in vitro diagnostic device design, development, distribution.
• Certification strengthens OaCP’s regulatory readiness for the EU IVDR framework, supporting scale-up and expansion in Italy, Europe.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio4Dreams SpA published the original content used to generate this news brief on July 29, 2026, and is solely responsible for the information contained therein.